390 related articles for article (PubMed ID: 34319857)
1. Virus-induced Volatile Organic Compounds Are Detectable in Exhaled Breath during Pulmonary Infection.
Kamal F; Kumar S; Edwards MR; Veselkov K; Belluomo I; Kebadze T; Romano A; Trujillo-Torralbo MB; Shahridan Faiez T; Walton R; Ritchie AI; Wiseman DJ; Laponogov I; Donaldson G; Wedzicha JA; Johnston SL; Singanayagam A; Hanna GB
Am J Respir Crit Care Med; 2021 Nov; 204(9):1075-1085. PubMed ID: 34319857
[No Abstract] [Full Text] [Related]
2. Exhaled volatile organic compounds discriminate patients with chronic obstructive pulmonary disease from healthy subjects.
Besa V; Teschler H; Kurth I; Khan AM; Zarogoulidis P; Baumbach JI; Sommerwerck U; Freitag L; Darwiche K
Int J Chron Obstruct Pulmon Dis; 2015; 10():399-406. PubMed ID: 25759572
[TBL] [Abstract][Full Text] [Related]
3. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
[TBL] [Abstract][Full Text] [Related]
4. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
[TBL] [Abstract][Full Text] [Related]
5. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
[TBL] [Abstract][Full Text] [Related]
6. Study of 5 Volatile Organic Compounds in Exhaled Breath in Chronic Obstructive Pulmonary Disease.
Jareño-Esteban JJ; Muñoz-Lucas MÁ; Gómez-Martín Ó; Utrilla-Trigo S; Gutiérrez-Ortega C; Aguilar-Ros A; Collado-Yurrita L; Callol-Sánchez LM
Arch Bronconeumol; 2017 May; 53(5):251-256. PubMed ID: 27780574
[TBL] [Abstract][Full Text] [Related]
7. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.
Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ
Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445
[TBL] [Abstract][Full Text] [Related]
8. Can exhaled volatile organic compounds predict asthma exacerbations in children?
van Vliet D; Smolinska A; Jöbsis Q; Rosias P; Muris J; Dallinga J; Dompeling E; van Schooten FJ
J Breath Res; 2017 Mar; 11(1):016016. PubMed ID: 28102830
[TBL] [Abstract][Full Text] [Related]
9. Measurement of exhaled volatile organic compounds from patients with chronic obstructive pulmonary disease (COPD) using closed gas loop GC-IMS and GC-APCI-MS.
Allers M; Langejuergen J; Gaida A; Holz O; Schuchardt S; Hohlfeld JM; Zimmermann S
J Breath Res; 2016 Apr; 10(2):026004. PubMed ID: 27058460
[TBL] [Abstract][Full Text] [Related]
10. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers.
Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD
J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711
[TBL] [Abstract][Full Text] [Related]
11. Exhaled volatile organic compounds for phenotyping chronic obstructive pulmonary disease: a cross-sectional study.
Basanta M; Ibrahim B; Dockry R; Douce D; Morris M; Singh D; Woodcock A; Fowler SJ
Respir Res; 2012 Aug; 13(1):72. PubMed ID: 22916684
[TBL] [Abstract][Full Text] [Related]
12. VOC biomarkers identification and predictive model construction for lung cancer based on exhaled breath analysis: research protocol for an exploratory study.
Li W; Dai W; Liu M; Long Y; Wang C; Xie S; Liu Y; Zhang Y; Shi Q; Peng X; Liu Y; Li Q; Duan Y
BMJ Open; 2019 Aug; 9(8):e028448. PubMed ID: 31399453
[TBL] [Abstract][Full Text] [Related]
13. Preliminary method for profiling volatile organic compounds in breath that correlate with pulmonary function and other clinical traits of subjects diagnosed with cystic fibrosis: a pilot study.
Woollam M; Siegel AP; Grocki P; Saunders JL; Sanders DB; Agarwal M; Davis MD
J Breath Res; 2022 Feb; 16(2):. PubMed ID: 35120338
[TBL] [Abstract][Full Text] [Related]
14. Volatile Organic Compounds in Exhaled Breath of Idiopathic Pulmonary Fibrosis for Discrimination from Healthy Subjects.
Yamada YI; Yamada G; Otsuka M; Nishikiori H; Ikeda K; Umeda Y; Ohnishi H; Kuronuma K; Chiba H; Baumbach JI; Takahashi H
Lung; 2017 Apr; 195(2):247-254. PubMed ID: 28247041
[TBL] [Abstract][Full Text] [Related]
15. Breathomics and treatable traits for chronic airway diseases.
Brinkman P; Zee AM; Wagener AH
Curr Opin Pulm Med; 2019 Jan; 25(1):94-100. PubMed ID: 30325789
[TBL] [Abstract][Full Text] [Related]
16. Exhaled Breath Profiles Before, During and After Exacerbation of COPD: A Prospective Follow-Up Study.
van Velzen P; Brinkman P; Knobel HH; van den Berg JWK; Jonkers RE; Loijmans RJ; Prins JM; Sterk PJ
COPD; 2019 Dec; 16(5-6):330-337. PubMed ID: 31588813
[TBL] [Abstract][Full Text] [Related]
17. Machine learning methods on exhaled volatile organic compounds for distinguishing COPD patients from healthy controls.
Phillips CO; Syed Y; Parthaláin NM; Zwiggelaar R; Claypole TC; Lewis KE
J Breath Res; 2012 Sep; 6(3):036003. PubMed ID: 22759349
[TBL] [Abstract][Full Text] [Related]
18. Identification of airway bacterial colonization by an electronic nose in Chronic Obstructive Pulmonary Disease.
Sibila O; Garcia-Bellmunt L; Giner J; Merino JL; Suarez-Cuartin G; Torrego A; Solanes I; Castillo D; Valera JL; Cosio BG; Plaza V; Agusti A
Respir Med; 2014 Nov; 108(11):1608-14. PubMed ID: 25269711
[TBL] [Abstract][Full Text] [Related]
19. A rapid method for breath analysis in cystic fibrosis patients.
Kramer R; Sauer-Heilborn A; Welte T; Guzman CA; Höfle MG; Abraham WR
Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):745-51. PubMed ID: 25431363
[TBL] [Abstract][Full Text] [Related]
20. Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPD.
Zhu J; Mallia P; Footitt J; Qiu Y; Message SD; Kebadze T; Aniscenko J; Barnes PJ; Adcock IM; Kon OM; Johnson M; Contoli M; Stanciu LA; Papi A; Jeffery PK; Johnston SL
J Allergy Clin Immunol; 2020 Oct; 146(4):840-850.e7. PubMed ID: 32283204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]